In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia Cavazzoni, M.D., stepped down in January and joined Pfizer's C-suite as chief ...

Danuglipron was the latest drug investors were hinging hope on to enter the obesity market.

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a ...

Healthcare & Pharmaceuticalscategory US CDC advisers begin review of vaccine guidelines after months-long delay 3:43 PM UTC · Updated ago Healthcare & Pharmaceuticalscategory Bristol Myers' heart ...

PARIS (Reuters) -Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, ...

The pharmaceutical giant scrapped development of a once-daily GLP-1 pill after a person involved in the drug’s trial suffered a liver injury.

The price of pharmaceuticals will likely go up soon, and generics are poised to be hit the hardest.

In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.

The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...

Examine, a free weekly newsletter covering science with a sceptical, evidence-based eye, is sent every Tuesday. You’re ...